News Results
There are 989,613 News Results
Mar 6, 2024
MINNEAPOLIS, March 6, 2024 /PRNewswire/ -- Dementia may be three times more common among people with essential tremor, a movement disorder that causes involuntary shaking, than the general population, according...
Mar 7, 2024
COPENHAGEN, Denmark, March 7, 2024 /PRNewswire/ -- BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, today announces that six companies are to receive additional...
Mar 7, 2024
Addition of CMO, Medical Director Chris Polage, MD, and enhancements in clinical operations position Company for success in the clinical development of ALX1 in bronchiectasis
Mar 7, 2024
Russo will serve a two year-term as an employer representative on the ACA, working to advance Registered Apprenticeships (RAs) and skills-based learning in advanced manufacturing
Mar 8, 2024
Dermatologist discusses emerging treatments in LGBTQ+ healthcare
Mar 8, 2024
Clinical studies presented at the 2024 American Academy of Dermatology Annual Meeting demonstrate how nature-based products support the microbiome in compromised skin, while improving barrier function and hydration
Mar 8, 2024
SILVER SPRING, Md., March 8, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of...
Mar 8, 2024
Steamroller Animation has announced that Shawn Dunn will be joining the studio as Chief Technology Officer. Dunn will be responsible for guiding and overseeing the studio's technology vision, most notably...
Mar 10, 2024
HANGZHOU and SHAOXING, China, March 10, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces the poster presentation of Phase II study final results of ASC40, a first-in-class...
Mar 12, 2024
-- Trial will evaluate IDE161, IDEAYA's investigational PARG inhibitor, in combination with KEYTRUDA(® )(pembrolizumab), Merck's anti-PD-1 therapy, in patients with MSI-high and MSS endometrial cancer -- Potential first-in-class PARG inhibitor,...